MATTA, LAURA
 Distribuzione geografica
Continente #
EU - Europa 17.358
NA - Nord America 499
AS - Asia 89
OC - Oceania 3
AF - Africa 2
Totale 17.951
Nazione #
IT - Italia 17.192
US - Stati Uniti d'America 498
CN - Cina 52
DE - Germania 41
SE - Svezia 41
UA - Ucraina 36
GB - Regno Unito 15
VN - Vietnam 12
FI - Finlandia 10
IN - India 7
BE - Belgio 6
FR - Francia 6
HK - Hong Kong 6
RO - Romania 4
SG - Singapore 4
AU - Australia 3
RS - Serbia 2
TH - Thailandia 2
AT - Austria 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KR - Corea 1
MX - Messico 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 17.951
Città #
Cagliari 17.131
Houston 62
Chandler 56
Ann Arbor 53
Fairfield 47
Woodbridge 37
Nyköping 29
Ashburn 25
Wilmington 24
Dearborn 21
Seattle 20
Cambridge 17
New York 14
Dong Ket 12
Jacksonville 11
Nanjing 11
Boston 10
Shanghai 10
Beijing 9
Boardman 8
Santadi 7
Brussels 6
Falls Church 6
Hong Kong 6
Rome 6
San Mateo 6
Helsinki 5
Sìnnai 5
Washington 4
Atlanta 3
Jiaxing 3
Sabaudia 3
San Diego 3
Sassari 3
Taizhou 3
Tianjin 3
Augusta 2
Bengaluru 2
Bitonto 2
Hebei 2
Mountain View 2
Norwalk 2
Phoenix 2
Pune 2
Redmond 2
Redwood City 2
Wuhan 2
Azor 1
Belgrade 1
Bologna 1
Bratislava 1
Brescia 1
Catania 1
Changsha 1
Copenhagen 1
Dolianova 1
Dolovo 1
Eugene 1
Freyung 1
Guangzhou 1
Hyderabad 1
Innsbruck 1
Jember 1
Jinan 1
Kunming 1
Leawood 1
Loma Linda 1
London 1
Longmont 1
Madison 1
Mengen 1
Monmouth Junction 1
Munich 1
Nanchang 1
Newcastle upon Tyne 1
Ningbo 1
Quartu Sant'elena 1
Radeberg 1
Randwick 1
Reggio Nell'emilia 1
Rochester 1
Salerno 1
San Sperate 1
Shenyang 1
Simi Valley 1
Sohag 1
Solihull 1
Sydney 1
Wandsworth 1
Zonguldak 1
Totale 17.744
Nome #
Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis 4.056
Killer cell immunoglobulin-like receptors and their HLA class I ligands in autoimmune hepatitis: a possible pathogenetic role ? 3.003
Role of interferon lambda 4 and ALT levels in optimising treatment of HCV for patients with low-stage fibrosis 2.636
Combination of IFNL4 polymorphisms and ALT reduction at 4 week of treatment with PEG IFN and Ribavirin is a new selection tool to optimize antiviral treatment allocation in HCV patients with low stage fibrosis 2.420
Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible? 2.386
INFLUENZA DEI POLIMORFISMI DELL’INTERFERONE LAMBDA NELLA STORIA NATURALE DELLA INFEZIONE CRONICA DA HBV: COINCIDENZA O REALTÀ? 2.137
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 1.360
Totale 17.998
Categoria #
all - tutte 20.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.130


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019159 0 0 0 0 0 0 0 0 0 0 72 87
2019/20204.386 226 123 20 54 1.637 1.229 661 92 51 69 66 158
2020/20215.584 129 229 209 1.869 1.059 550 347 317 160 300 277 138
2021/2022764 106 45 18 69 88 42 25 29 113 93 94 42
2022/2023920 88 174 173 75 84 62 23 74 36 40 57 34
2023/2024834 60 102 47 75 86 148 127 62 61 53 13 0
Totale 17.998